Surgical removal supplements would reduce the risk of developing Parkinson's disease, according to a study published by Associated Press last Wednesday. The importance of adding to the human body – if any – has already been subject to speculation, but scientists now claim that it can play a role in the development of Parkinson's disease, Agerpres says.
A group of over one million people have discovered that surgical removal of the supplements will be associated with a 20% reduction in degenerative diseases. Specifically, scientists from the US Advanced Science Association investigated the link between Parkinson's disease and supplements, which have been shown to contain a significant amount of protein accumulating in the brain of affected patients. Researchers have studied a set of epidemiological data that contains demographic and statistics on Parkinson's disease of 1.6 million people in Sweden and found that appendectomy – the surgical removal procedure – reduced the overall risk of this condition by 19.3%. Analyzes conducted at a second set of data from 849 patients with Parkinson's Disease found that apendectomy was associated with an average postponement of 3.6 years after the onset of the disorder.
The study was published in the science journal Science Translational Medicine, completed at the Agerpres site.